TRLV news

Latest 2 stories · newest Nov 5, 2026

TRLV

Trulieve reports Q3 2026 revenue of $230M

Trulieve reported milestone regulatory approval and strong Q3 2026 results, with higher margins and free cash flow meeting market expectations for a resilient medical cannabis platform.

Earnings Nov 5, 2026 sentiment +0.30 SEC filing ↗

TRLV

Trulieve Q2 2026 Earnings Report and NYSE IPO

Trulieve reported Q2 2026 revenue of $271 million and cash flow of $109 million, while becoming the first U.S. cannabis company listed on the NYSE. The company completed the deconsolidation of Harvest and announced an $50M share repurchase program.

Earnings|Guideance|Offering Aug 7, 2026 sentiment +0.40 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same TRLV feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/TRLV/newsSTART FREE